Early cancer detection has long been one of medicine's greatest challenges. Many cancers do not cause noticeable symptoms ...

The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage for it to become widely available.

A host of companies are competing to bring cancer-detecting blood tests to market.

Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over 12,000 men in Sweden.

Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...

Freenome, an early cancer detection company developing blood-based screening tests, today announced favorable results from its pivotal clinical validation study assessing the performance of assay and ...

A new study suggests the investigational Stockholm3 blood test may improve the early detection of aggressive prostate cancer compared with the standard PSA test.

A non-invasive brush test can diagnose mouth cancer within one hour, potentially boosting detection rates, a new study says.

Northwestern Medicine scientists have demonstrated that a highly sensitive blood test can detect traces of pancreatic cancer ...

A new non-invasive brush test can detect mouth cancer within an hour, enabling faster diagnosis, earlier treatment, and ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield™ blood test for colorectal cancer screening (CRC) is now covered for eligible UnitedHealth Group ...